Table of Contents - Haematologica

7 downloads 0 Views 641KB Size Report
Jin Han et al. http://www.haematologica.org/content/102/8/e282 e285 NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human ...
haematologica Journal of the European Hematology Association Published by the Ferrata Storti Foundation

Table of Contents Volume 102, Issue 8: August 2017 Cover Figure Image generated by www.somersault1824.com.

Editorials 1299

p27 in FLT3-driven acute myeloid leukemia: many roads lead to ruin Iris Z Uras, Florian Bellutti and Veronika Sexl

1301

Long non-coding RNAs: another brick in the wall of normal karyotype acute myeloid leukemia? Bruno C. Medeiros

Guideline Article 1304

Recommendations regarding splenectomy in hereditary hemolytic anemias Achille Iolascon et al.

Articles Red Cell Biology & its Disorders

1314

Extracellular glycine is necessary for optimal hemoglobinization of erythroid cells Daniel Garcia-Santos et al.

Hemostasis

1324

Patient-derived anti-β2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues Philippe de Moerloose et al.

Platelet Biology & its Disorders

1333

Risk of cardiovascular events and pulmonary hypertension following splenectomy – a Danish population-based cohort study from 1996-2012 Marianne Rørholt et al.

1342

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia Douglas B. Cines et al.

Myeloproliferative Disorders

1352

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome Sa A. Wang et al.

Chronic Myeloid Leukemia

1361

Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib Stein-Erik Gullaksen et al.

1368

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study Delphine Rea et al.

Haematologica 2017; vol. 102 no. 8 - August 2017 http://www.haematologica.org/

haematologica Journal of the European Hematology Association Published by the Ferrata Storti Foundation Acute Myeloid Leukemia

1378

FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia Ines Peschel et al.

1391

Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia Dimitrios Papaioannou et al.

Chronic Lymphocytic Leukemia

1401

Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells Elena Tibaldi et al.

Non-Hodgkin Lymphoma

1413

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium Wendy B.C. Stevens et al.

Plasma Cell Disorders

1424

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up Ute Hegenbart et al.

1432

Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation Maximilian Merz et al.

1439

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation Rajshekhar Chakraborty et al.

Cell Therapy & Immunotherapy

1446

Tbet is a critical modulator of FoxP3 expression in autoimmune graft-versus-host disease Shoba Amarnath et al.

1457

Shorter leukocyte telomere length is associated with higher risk of infections: a prospective study of 75,309 individuals from the general population Jens Helby et al.

Letters to the Editor Letters are available online only at www.haematologica.org/content/102/8.toc

e282

Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways Jin Han et al. http://www.haematologica.org/content/102/8/e282

e285

NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors

Xingguo Zhu et al. http://www.haematologica.org/content/102/8/e285

e289

Absence of the spleen and the occurrence of primary red cell alloimmunization in humans Dorothea Evers et al. http://www.haematologica.org/content/102/8/e289

e293

Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies Shirleny R. Cardoso et al. http://www.haematologica.org/content/102/8/e293

Haematologica 2017; vol. 102 no. 8 - August 2017 http://www.haematologica.org/

haematologica Journal of the European Hematology Association Published by the Ferrata Storti Foundation

e297

E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy Simone Claudiani et al. http://www.haematologica.org/content/102/8/e297

e300

Amplification of mixed lineage leukemia gene perturbs hematopoiesis and cooperates with partial tandem duplication to induce acute myeloid leukemia Bon Ham Yip et al. http://www.haematologica.org/content/102/8/e300

e305

Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia Tamara Bittolo et al. http://www.haematologica.org/content/102/8/e305

e310

Clinical and diagnostic relevance of NOTCH2 and KLF2 mutations in splenic marginal zone lymphoma Yolanda Campos-Martín et al. http://www.haematologica.org/content/102/8/e310

e313

The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype Carolina Schinke et al. http://www.haematologica.org/content/102/8/e313

e317

Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma Isabel J.F. Hofman et al. http://www.haematologica.org/content/102/8/e317

e321

Dynamics of epigenetic age following hematopoietic stem cell transplantation Friedrich Stölzel et al. http://www.haematologica.org/content/102/8/e321

Case Reports Case Reports are available online only at www.haematologica.org/content/102/8.toc

e324

JAK1 somatic mutation in a myeloproliferative neoplasm Suzanne O. Arulogun et al. http://www.haematologica.org/content/102/8/e324

e328

p.Y317H is a new JAK2 gain-of-function mutation affecting the FERM domain in a myelofibrosis patient with CALR mutation Laura Eder-Azanza et al. http://www.haematologica.org/content/102/8/e328

Haematologica 2017; vol. 102 no. 8 - August 2017 http://www.haematologica.org/